CN115261319B - 一种多肽诱导扩增的nk细胞及用于细胞治疗的用途 - Google Patents
一种多肽诱导扩增的nk细胞及用于细胞治疗的用途 Download PDFInfo
- Publication number
- CN115261319B CN115261319B CN202211044084.XA CN202211044084A CN115261319B CN 115261319 B CN115261319 B CN 115261319B CN 202211044084 A CN202211044084 A CN 202211044084A CN 115261319 B CN115261319 B CN 115261319B
- Authority
- CN
- China
- Prior art keywords
- cells
- polypeptide
- cell
- tumor
- induction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211044084.XA CN115261319B (zh) | 2022-08-30 | 2022-08-30 | 一种多肽诱导扩增的nk细胞及用于细胞治疗的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211044084.XA CN115261319B (zh) | 2022-08-30 | 2022-08-30 | 一种多肽诱导扩增的nk细胞及用于细胞治疗的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115261319A CN115261319A (zh) | 2022-11-01 |
CN115261319B true CN115261319B (zh) | 2023-08-18 |
Family
ID=83755437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211044084.XA Active CN115261319B (zh) | 2022-08-30 | 2022-08-30 | 一种多肽诱导扩增的nk细胞及用于细胞治疗的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115261319B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117003831B (zh) * | 2023-08-11 | 2024-03-19 | 中邦干细胞科技有限公司 | 一种多肽诱导扩增的nk细胞及用于细胞治疗的用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104651310A (zh) * | 2015-02-28 | 2015-05-27 | 杭州中德贝尔生物科技有限公司 | 一种体外诱导扩增nk细胞的方法 |
CN111620932A (zh) * | 2020-06-30 | 2020-09-04 | 南京赛尔健生物技术有限公司 | 一种多肽及在促进nk细胞增殖和提高其对肿瘤细胞杀伤力方面的应用 |
CN111718399A (zh) * | 2020-06-30 | 2020-09-29 | 南京赛尔健生物技术有限公司 | 一种多肽及用于nk细胞培养、制备nk细胞培养基的用途 |
-
2022
- 2022-08-30 CN CN202211044084.XA patent/CN115261319B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104651310A (zh) * | 2015-02-28 | 2015-05-27 | 杭州中德贝尔生物科技有限公司 | 一种体外诱导扩增nk细胞的方法 |
CN111620932A (zh) * | 2020-06-30 | 2020-09-04 | 南京赛尔健生物技术有限公司 | 一种多肽及在促进nk细胞增殖和提高其对肿瘤细胞杀伤力方面的应用 |
CN111718399A (zh) * | 2020-06-30 | 2020-09-29 | 南京赛尔健生物技术有限公司 | 一种多肽及用于nk细胞培养、制备nk细胞培养基的用途 |
Also Published As
Publication number | Publication date |
---|---|
CN115261319A (zh) | 2022-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95119854A (ru) | Ингибитор пролиферации стволовых клеток и его использование | |
CN111420030B (zh) | Fgf21在制备用于治疗结直肠癌药物中的应用 | |
CN115261319B (zh) | 一种多肽诱导扩增的nk细胞及用于细胞治疗的用途 | |
CN113307845B (zh) | 促进肝细胞增殖和/或抑制肝细胞凋亡的多肽及其用途 | |
CN102343086A (zh) | 治疗或预防肿瘤的药物、肿瘤全细胞疫苗及其制备方法和用途 | |
EP0593625B1 (en) | Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity | |
CN110606871A (zh) | 一种小分子多肽rk12及其应用 | |
CN106565828B (zh) | 诱导dc-cik细胞的多肽及其在肿瘤细胞治疗中的应用 | |
EP0950416A1 (en) | Preventive and/or therapeutic agent for cachexia | |
CN112029730A (zh) | 一种基因修饰的间充质干细胞及其应用 | |
TW200920387A (en) | Composition of mushroom beta-glucan for anti-cancer and preparation method thereof | |
CN112641924A (zh) | 一种治疗甲状腺癌的药物及其制备方法和用途 | |
CN106676068B (zh) | 一种生物活性肽和体外扩增cik细胞的方法 | |
CN111647656A (zh) | mir-29a基因在检测肝癌及肝纤维化中的应用及所述基因条件敲入小鼠的构建方法 | |
CN106928325B (zh) | 增强肝癌细胞对cik细胞杀伤敏感性的人工多肽及其生物制品 | |
CN112370444B (zh) | 一种pd-1/pd-l1抑制剂及其应用 | |
CN108409866A (zh) | 一种用于治疗和预防人乳头瘤病毒感染及相关疾病的多表位组合肽 | |
JPS60501558A (ja) | インタ−フエロン感受性疾病の治療方法およびγ−インタ−フエロン含有製剤の製造方法および装置 | |
CN106801036B (zh) | 一种生物活性肽及用其体外高效扩增cik细胞的方法 | |
CN116490196A (zh) | 通过处理白细胞介素-33制备免疫原性提高的分化簇103+fcgr3+树突状细胞的方法以及包含上述树突状细胞的用于免疫抗癌治疗的药物组合物 | |
CN116983389A (zh) | 半乳糖凝集素9在制备治疗转移性肝癌药物中的用途 | |
CN114478697A (zh) | 一种五肽和用于提高nk细胞杀伤力的用途 | |
CN117286042A (zh) | 一种增强pd-1单抗治疗效应的罗伊氏乳杆菌株及其应用 | |
CN101475636B (zh) | 人干扰素样蛋白及其用途 | |
CN116768982A (zh) | 一种多肽及其在制备防治肿瘤的药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230724 Address after: Room 2108, Building 3, No. 78, Dongcheng Section, Guanlong Road, Dongcheng Street, Dongguan City, Guangdong Province, 523000 Applicant after: Guangdong Qimei Life Medicine Technology Research Institute Applicant after: Guangdong Qimei Pharmaceutical Biotechnology Group Co.,Ltd. Applicant after: Zhuhai Qimei Stem Cell Bank Co.,Ltd. Applicant after: Guangdong Stanfu International Stem Cell Medical Research Institute Address before: 202155 No. 492, Shanghai Chengqiao Economic Development Zone, Chongming District, Shanghai Applicant before: Suxuan (Shanghai) Biotechnology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |